A Phase II Study of AS1411 in Renal Cell Carcinoma
The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
DRUG: AS1411
To determine the Overall Response Rate to AS1411
To measure progression free survival with AS1411|To measure time to disease progression with AS1411|To measure the duration of overall response and stable disease with AS1411|To determine the safety and tolerability of two cycles of AS1411|To assess the pharmacokinetic profile of AS1411|To assess pharmacodynamic markers of AS1411
The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma